QA: Crescent Biopharma INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001253689_2020_Crescent_Biopharma_INC.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001253689, Crescent Biopharma INC

  xvar xval
0 AssetsCurrent 162,527,763
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 822,920
3 remainder_Assets 4,618,996
4 LiabilitiesCurrent 10,950,576
5 LiabilitiesNoncurrent 2,818,516
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,827,600
9 ResearchAndDevelopmentExpense 50,391,830
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,615,753
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 167,969,679
1 Liabilities 13,769,092
2 Expenses 66,219,430
3 Revenues 0
4 StockholdersEquity 154,200,587
5 NetIncome -62,603,677
6 ComprehensiveNetIncome -62,603,677
7 BaseVar 125,786,977
8 EconomicCapitalRatiobeforeLimitedLiability 3.01
9 EconomicCapitalRatio 3.69

Edgar->Model Mapping

Feature Distribution

Change over Time